Schering Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCHERING, and what generic and branded alternatives to SCHERING drugs are available?
SCHERING has one hundred and one approved drugs.
Drugs and US Patents for Schering
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | NAQUA | trichlormethiazide | TABLET;ORAL | 012265-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | GARAMYCIN | gentamicin sulfate | INJECTABLE;INJECTION | 061716-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | PERMITIL | fluphenazine hydrochloride | TABLET;ORAL | 012034-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering | PROVENTIL | albuterol sulfate | TABLET;ORAL | 017853-001 | May 7, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Schering Plough | AFRINOL | pseudoephedrine sulfate | TABLET, EXTENDED RELEASE;ORAL | 018191-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Schering
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | DIPROLENE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 019408-001 | Jan 31, 1986 | 4,482,539 | ⤷ Try a Trial |
Schering | VANCERIL | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 017573-001 | Approved Prior to Jan 1, 1982 | 4,414,209 | ⤷ Try a Trial |
Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | 3,660,577 | ⤷ Try a Trial |
Schering | REBETOL | ribavirin | SOLUTION;ORAL | 021546-001 | Jul 29, 2003 | 6,172,046*PED | ⤷ Try a Trial |
Schering | NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003-001 | Sep 15, 2006 | 8,263,600 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SCHERING drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 100 mg | ➤ Subscribe | 2014-06-16 |
➤ Subscribe | Oral Suspension | 40 mg/mL | ➤ Subscribe | 2011-02-28 |
➤ Subscribe | Injection | 18 mg/mL, 16.7 mL vials | ➤ Subscribe | 2015-11-24 |
Similar Applicant Names
Here is a list of applicants with similar names.